Search clinical trials for: Depressive Episode

Total 49716 results

Academisch Medisch Centrum - Universiteit van Amsterdam...
ZonMw: The Netherlands Organisation for Health Research and Development

Unknown

Relapse Prevention in First Episode Schizophrenia: a 5 Year Trial

Schizophrenia

Netherlands
University of California, Los Angeles
National Institute of Mental Health (NIMH)

Completed

Improving Work Outcome in People With Recent-onset Schizophrenia

Schizophrenia

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes

Bipolar Disorder

United States, Ukraine, Taiwan, Spain, Poland, India, Malaysia, Russian Federation, Slovakia, Austria
Janssen Pharmaceutica N.V., Belgium

Completed

Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode

Schizophrenia

United Kingdom, Slovenia, Denmark, Finland, France, Greece, Israel, Norway, Sweden, Switzerland
AstraZeneca

Completed

Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia (RECONNECT-S)

Schizophrenia

United Arab Emirates, Egypt, Saudi Arabia
The Medical Research Network
Pfizer; Liebowitz, Michael R., M.D.

Completed

Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression

Major Depressive Episode | Bipolar II Disorder

United States
Melbourne Health
National Institute of Mental Health (NIMH)

Completed

Indicated Prevention of Psychotic Disorders With Low-dose Lithium

Psychotic Disorders | Schizophrenia | Bipolar Disorder

Australia
Tri-Service General Hospital

Completed

Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar Disorder (OCTLPODEPWBD)

Bipolar Disorder

Taiwan
INTRuST, Post-Traumatic Stress Disorder - Traumatic...
Medical University of South Carolina; University of California, San Diego; U.S... and other collaborators

Unknown

Transcranial Magnetic Stimulation (TMS) for Suicidal Ideation

Traumatic Brain Injury | Posttraumatic Stress Disorder | Depressive Episode

United States
Northside Clinic, Australia
Wesley Mission

Completed

Ketamine as an Anaesthetic Agent in Electroconvulsive Therapy (ECT)

Major Depressive Episode

Australia
Sanofi

Completed

An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients (FIDELIO)

Major Depressive Disorder

Romania, Russian Federation, Ukraine, Mexico, Slovakia, Chile, South Africa
The University of New South Wales
Wesley Mission

Unknown

A Study of Ketamine as an Antidepressant

Major Depressive Episode

Australia
AstraZeneca
University of North Carolina

Completed

CAFE Comparison of Atypicals in First Episode of Psychosis

Mental Disorders | Psychotic Disorders | Schizophrenia | Mental Health

United States, Canada
AstraZeneca

Completed

Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia

Schizophrenia | Acute Psychotic Episode

Hungary, Latvia, Romania
University of Zurich

Unknown

Randomized Clinical Trial of an Exposure-based Cognitive Therapy for Depression

Unipolar Depression

Switzerland
Otsuka Pharmaceutical Development & Commercialization...

Completed

Aripiprazole Open-Label, Safety and Tolerability Study (APEX 241)

Schizophrenia | Bipolar Disorder

United States
Peking University

Completed

Multicenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment of Agitated Symptoms in the Patients With Acute Episode of Schizophrenia

Schizophrenia
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection

Graft Rejection

United Kingdom, Canada, Taiwan, United States, France, Belgium, Spain, Australia, Germany, New Zealand, Argentina, Italy, Austria, Norway, Puerto Rico
Pfizer

Completed

Abuse Potential of Orally Administered Crushed Embeda Compared to Crushed Controlled-Release Morphine and Placebo in Non-Dependent Recreational Opioid Users

Nondependent Opioid Abuse, Episodic

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

Aripiprazole in Children and Adolescents With Bipolar I Disorder

Bipolar Disorder

United States
Sheba Medical Center

Completed

Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode

Mania

Israel, Romania
Nycomed

Completed

Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)

Cancer

Denmark
Nycomed

Completed

Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM)

Pain | Cancer

Denmark
Xijing Hospital

Unknown

Repetitive Transcranial Magnetic Stimulation for First-episode Schizophrenia Patients (rTMSfMRI)

Schizophrenia

China
Chonbuk National University Hospital
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Aripiprazole in First Episode Psychosis

First Episode Psychosis

Korea, Republic of
Shalvata Mental Health Center

Unknown

Evaluation of the H-Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for Treatment of Major Depressive Episode in the Elderly

Depression

Israel
Northwell Health
National Institute of Mental Health (NIMH); The Zucker Hillside Hospital

Completed

Treatment for First-Episode Schizophrenia

Schizophrenia

United States
Shalvata Mental Health Center
Brainsway

Completed

Evaluation of the H-coil Transcranial Magnetic Stimulation TMS Device - Safety and Feasibility Study for Acute and Maintenance Treatment in Major Depressive Episode

Major Depressive Disorder

Israel
AstraZeneca

Completed

Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect (UPTAQE)

Schizophrenia | Mania

Netherlands
University of Regensburg
AstraZeneca

Completed

Quetiapine Induced Neuroplasticity in First-episode Schizophrenic Patients

Schizophrenia

Germany
Birte Glenthoj
Rigshospitalet, Denmark; University of Copenhagen; Hvidovre University Hospital; The Novo Nordic Foundation and other collaborators

Completed

Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia

Schizophrenia

Denmark
Birte Glenthoj
AstraZeneca; Rigshospitalet, Denmark; University of Copenhagen; Glostrup University... and other collaborators

Completed

Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia

Schizophrenia

Denmark
Aristotle University Of Thessaloniki
AHEPA University Hospital

Completed

Role of Droperidol in Postoperative Vomiting

Vomiting

Greece
Institut fuer anwendungsorientierte Forschung und...
University of Göttingen

Completed

Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot Study

Schizophrenia

Germany
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.

Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder

Bipolar Disorder | Mania | Affective Psychosis, Bipolar
University of North Carolina, Chapel Hill
Eli Lilly and Company

Completed

Study of Amantadine for Weight Stabilization During Olanzapine Treatment

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychotic Disorder | Mood Disorders With Psychotic Features

United States
Dr. D McIntosh & Dr. K Kjernisted Clinical Research...
AstraZeneca

Unknown

Measuring Response to Depression Treatment

Depression

Canada
The University of Hong Kong

Completed

Antipsychotic Therapy and First Episode

Schizophrenia

Hong Kong
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol

Bipolar Disorders | Manic Disorder
AstraZeneca

Completed

Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode Psychosis

Psychosis

Australia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder

Bipolar Disorders | Manic Disorder
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Bipolar Disorder | Manic Episode
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder

Bipolar Disorders | Manic Episode
Eli Lilly and Company

Completed

Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder

Manic or Mixed Episode Associated With Bipolar I Disorder

Japan
Eli Lilly and Company

Completed

Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder

Bipolar Disorder

Japan
AstraZeneca

Completed

A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder (HARMONY)

Bipolar Disorders

Belgium
AstraZeneca

Completed

A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine) (SEQUEL)

Schizophrenia | Bipolar Disorder

Netherlands
AstraZeneca

Completed

Depressive Symptoms in Acute Manic Episode (MM1)

Bipolar Disorder

Spain
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.

Bipolar Disorder | Manic Disorder

Search clinical trials for: Depressive Episode

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations